WithdrawnNot Applicable

Dynamic Contrast-Enhanced Fluorescence Arthroscopy of Meniscus Pilot

Stopped: At the time of writing the protocol, was unaware that there is already an established protocol in place within Geriatrics department to capture this data.

United States0Started 2022-01-12

Plain-language summary

Single-center pilot prospective observational study to determine feasibility of assessing meniscal tissue vascularity using dynamic contrast-enhanced fluorescence arthroscopy

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Patients 18 years of age or older.
. Meniscal tear based on MRI or preoperative assessment
. Provision of informed consent.

Exclusion criteria

. Inability of patient to provide informed consent
. Iodine allergy.
. Evidence of septic arthritis of the proposed surgical joint.
. Burns.
. Incarceration.
. Expected survival of less than 90 days.
. Problems, in the judgment of study personnel, with maintaining follow-up with the patient.
. Pregnant or Breastfeeding Women

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Measurement of meniscal blood supply using Indocyanine green (ICG)

Timeframe: Baseline, up to 20 minutes

Trial details

NCT IDNCT05072717

SponsorDartmouth-Hitchcock Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-30

View on ClinicalTrials.gov More Knee Injuries trials